MIROVA

13F Filings History

Latest 13F report
Q3 2024 - Nov 13, 2024
Value $
$579M
Signature - Title
Violaine Olivier Mainguy - CHIEF COMPLIANCE OFFICER
Location
Paris, France
Summary
This page shows a list of all the recent 13F filings made by MIROVA. Form 13F is required to be filed within 45 days of the end of a calendar quarter. MIROVA reported 120 stock holdings with total value $579M as of Q3 2024. Top holdings included TMO, ACN, ECL, NVDA, and MSFT.
Holdings Value

List of Other Managers Reporting for MIROVA:

Name Holdings Value Location File Number
Mirova US LLC $8.72B Boston, MA 028-20101
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q3 2024 120 $579M +$28.8M -$33.7M -$4.84M TMO, ACN, ECL, NVDA, MSFT 13F-HR 11/13/2024, 04:09 PM
Q2 2024 123 $547M +$72.5M -$53.5M +$18.9M TMO, ACN, ECL, NVDA, MSFT 13F-HR 8/13/2024, 04:01 PM
Q1 2024 135 $565M +$118M -$76M +$42.3M TMO, ACN, ECL, NVDA, MSFT 13F-HR 5/13/2024, 04:00 PM
Q4 2023 126 $488M +$26.3M -$94.8M -$68.5M TMO, ACN, ECL, GIB, ENPH 13F-HR 2/13/2024, 04:00 PM
Q3 2023 126 $497M +$35.4M -$52.3M -$16.9M TMO, ACN, ENPH, GIB, ECL 13F-HR 11/14/2023, 06:42 AM
Q2 2023 163 $568M +$17.5M -$148M -$131M TMO, ENPH, ACN, RUN, ECL 13F-HR 8/11/2023, 04:11 PM
Q1 2023 164 $693M +$136M -$110M +$25.6M TMO, ECL, ENPH, RUN, ACN 13F-HR 5/12/2023, 04:01 PM
Q4 2022 181 $639M +$50.8M -$39.8M +$11M TMO, ECL, RUN, GIB, MSFT 13F-HR 2/13/2023, 04:48 PM
Q3 2022 171 $594M +$50.3M -$130M -$79.6M TMO, ECL, RUN, GIB, MSFT 13F-HR 11/14/2022, 11:03 AM
Q2 2022 171 $704M +$99.5M -$39.4M +$60.1M TMO, ECL, RUN, MSFT, GIB 13F-HR 8/12/2022, 04:20 PM
Q1 2022 174 $747M +$96.7M -$90.1M +$6.61M TMO, ECL, RUN, MSFT, GIB 13F-HR 5/13/2022, 04:00 PM
Q4 2021 172 $835M +$122M -$106M +$16.3M TMO, ECL, RUN, BLDP, WOLF 13F-HR 2/14/2022, 12:19 PM
Q3 2021 165 $777M +$36.3M -$65.2M -$28.9M TMO, ECL, RUN, BLDP, CREE 13F-HR 11/12/2021, 04:02 PM
Q2 2021 165 $834M +$28.6M -$43.4M -$14.8M TMO, ECL, RUN, BLDP, FSLR 13F-HR 8/13/2021, 01:18 PM
Q1 2021 164 $838M +$175M -$100M +$74.5M TMO, ECL, RUN, BLDP, FSLR 13F-HR 5/14/2021, 10:53 AM
Q4 2020 163 $778M +$182M -$127M +$54.8M ECL, TMO, ITRI, BLDP, RUN 13F-HR 2/12/2021, 12:57 PM
Q3 2020 195 $621M +$137M -$149M -$11.6M TMO, ECL, VSLR, ITRI, DHR 13F-HR 11/12/2020, 04:01 PM
Q2 2020 175 $436M +$108M -$7.16M +$101M TMO, ECL, DHR, VSLR, FSLR 13F-HR 8/13/2020, 09:35 AM
Q1 2020 173 $264M +$57.6M -$32.4M +$25.2M TMO, ECL, FSLR, DHR, GIB 13F-HR 5/14/2020, 02:59 PM
Q4 2019 177 $287M +$29.3M -$605M -$576M TMO, ECL, DHR, FSLR, GIB 13F-HR 2/14/2020, 08:33 AM
Q3 2019 127 $811M +$12.7M -$355M -$342M TMO, ECL, DHR, MSFT, MA 13F-HR 11/13/2019, 01:19 PM
Q2 2019 129 $1.13B +$937M -$3.2M +$934M TMO, ECL, DHR, MA, MSFT 13F-HR 8/13/2019, 09:06 AM
Q1 2019 99 $184M +$26.3M -$95.6M -$69.3M TMO, ECL, GIB, DHR, NVDA 13F-HR 5/15/2019, 08:31 AM
Q4 2018 95 $219M $0 $0 TMO, ECL, DHR, GIB, CRTO 13F-HR 2/14/2019, 12:57 PM